BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15772959)

  • 1. Expression of epidermal growth factor receptor, ERBB2 and KIT in adult soft tissue sarcomas: a clinicopathologic study of 281 cases.
    Sato O; Wada T; Kawai A; Yamaguchi U; Makimoto A; Kokai Y; Yamashita T; Chuman H; Beppu Y; Tani Y; Hasegawa T
    Cancer; 2005 May; 103(9):1881-90. PubMed ID: 15772959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C; Voigt JJ; Laplanche A; Culine S; Lortholary A; Bugat R; Theodore C; Priou F; Kaminsky MC; Lesimple T; Pivot X; Coudert B; Douillard JY; Merrouche Y; Fizazi K
    Br J Cancer; 2007 Oct; 97(7):857-61. PubMed ID: 17876336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of HER-2/neu, c-kit (CD117) and vascular endothelial growth factor (VEGF) overexpression in soft tissue sarcomas.
    Potti A; Ganti AK; Foster H; Knox S; Hebert BJ; Tendulkar K; Sholes K; Koch M; Kargas S
    Anticancer Res; 2004; 24(1):333-7. PubMed ID: 15015617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
    Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
    Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE; Pollice AA; Smith CA; Janocko LE; Sweeney L; Brown KA; Singh SG; Gu L; Yakulis R; Lucke JF
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC4 and ERBB2 expression in major and minor salivary gland mucoepidermoid carcinoma.
    Weed DT; Gomez-Fernandez C; Pacheco J; Ruiz J; Hamilton-Nelson K; Arnold DJ; Civantos FJ; Zhang J; Yasin M; Goodwin WJ; Carraway KL
    Head Neck; 2004 Apr; 26(4):353-64. PubMed ID: 15054739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A; Winter K; Wu CL; Kaufman D; Hammond E; Parliament M; Tester W; Hagan M; Grignon D; Heney N; Pollack A; Sandler H; Shipley W
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):309-17. PubMed ID: 15890569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients.
    DiGiovanna MP; Stern DF; Edgerton SM; Whalen SG; Moore D; Thor AD
    J Clin Oncol; 2005 Feb; 23(6):1152-60. PubMed ID: 15718311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumors.
    Tawbi H; Thomas D; Lucas DR; Biermann JS; Schuetze SM; Hart AL; Chugh R; Baker LH
    Oncologist; 2008 Apr; 13(4):459-66. PubMed ID: 18448562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of epidermal growth factor receptor expression in colon cancer patients undergoing curative surgery.
    Galizia G; Lieto E; Ferraraccio F; De Vita F; Castellano P; Orditura M; Imperatore V; La Mura A; La Manna G; Pinto M; Catalano G; Pignatelli C; Ciardiello F
    Ann Surg Oncol; 2006 Jun; 13(6):823-35. PubMed ID: 16614884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach.
    Bar-Sela G; Kuten A; Ben-Eliezer S; Gov-Ari E; Ben-Izhak O
    Mod Pathol; 2003 Oct; 16(10):1035-40. PubMed ID: 14559987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
    Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
    Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical analysis of expression of a 65 kDa oncofetal protein (p65), epidermal growth factor receptor (EGFR), oncogene c-erb B2 and tumor suppressor gene p53 protein products in breast cancer patients.
    Niewiadomska H; Mirowski M; Stempień M; Błoński JZ; Czyz W; Switalska J; Matyga E; Hanausek M; Wierzbicki R
    Neoplasma; 2000; 47(1):8-14. PubMed ID: 10870681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
    Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
    Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
    Lager DJ; Slagel DD; Palechek PL
    Mod Pathol; 1994 Jun; 7(5):544-8. PubMed ID: 7937720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.